The 1st Seminar of Biotechnology and Pharmaceutical Engineering Research Center/Toyama Pharmaceutical Valley Development Consortium
The COVID-19 pandemic that broke out the year before last has led to rapid
progress in the production of mRNA vaccines and other products around the
world, and many new modalities classified by their components, such as
"mRNA drugs" and "nucleic acid drugs," have emerged.
We will also introduce a case study of Chugai Pharmaceutical Co., Ltd.
which has been promoting its business by successfully implementing both
wheels of drug discovery and drug development (expansion of indications)
by utilizing its unique antibody engineering technology in the domestic
and overseas pharmaceutical markets.
We are looking forward to your application!
Biopharma lecture on November 4
Thursday, October 6, 2022 - Thursday, November 3, 2022
Please apply on an individual basis using the application form on the right.
① Fill in the necessary information on the application form above and send it.
② You will receive a reply email (registration complete) after application, and later receive the Zoom URL.
③ Click on the Zoom URL on the day
④ Participate in the lecture
※If you do not receive a reply email, please contact us.
・You need to apply in advance.
・Please access the URL 5 minutes before the lecture starts.
・Making audio and video recordings, and publication are prohibited.
Toyama Pharmaceutical Valley Development Consortium, TPU